Ostarine vexes anti-doping agencies

A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite sport – and the scientist who discovered it now spends more time trying to stop people using it than encouraging its medical use. Tom Bassindale of Sheffield Hallam University explains in The Conversation.